Obesity & Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diabetes
Preliminary optimal indication for nateglinide released
May 31st, 2004
Researchers released preliminary recommendations for optimal indication for nateglinide in a recent issue of Advances in Therapy. "Insulin secretion dynamics and response to nateglinide were studied-in patients with type 2 diabetes and reduced early-phase insulin secretion. On day 1, 24 patients underwent a 75-g oral glucose tolerance test without taking nateglinide. On day 2, they were given oral nateglinide 90 mg immediately before the oral glucose tolerance test," scientists in Japan report. "After glucose loading, insulin levels increased significantly at 30, 60, 90, and 120 minutes after the patients took nateglinide, along with...
Source: Obesity & Diabetes Week (2004-05-31)
|
